M Harzic

1.4k total citations
26 papers, 779 citations indexed

About

M Harzic is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, M Harzic has authored 26 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Virology and 10 papers in Infectious Diseases. Recurrent topics in M Harzic's work include HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). M Harzic is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). M Harzic collaborates with scholars based in France, United States and Canada. M Harzic's co-authors include Isabelle Pellegrin, Françoise Brun‐Vézinet, Christiane Deveau, Laurence Meyer, D. Séréni, Cécile Goujard, A Venet, Christine Rouzioux, Marie‐Laure Chaix and Nicole Ngo‐Giang‐Huong and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

M Harzic

25 papers receiving 756 citations

Peers

M Harzic
Susan Phillips United States
M. Dia Senegal
Stefan Lindbäck Sweden
Perpétua Gómes Portugal
N. Hallam United Kingdom
P Pehrson Sweden
Lars Moberg Sweden
F de Wolf Netherlands
Milenka V. Vargas United States
H. Farzadegan United States
Susan Phillips United States
M Harzic
Citations per year, relative to M Harzic M Harzic (= 1×) peers Susan Phillips

Countries citing papers authored by M Harzic

Since Specialization
Citations

This map shows the geographic impact of M Harzic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Harzic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Harzic more than expected).

Fields of papers citing papers by M Harzic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Harzic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Harzic. The network helps show where M Harzic may publish in the future.

Co-authorship network of co-authors of M Harzic

This figure shows the co-authorship network connecting the top 25 collaborators of M Harzic. A scholar is included among the top collaborators of M Harzic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Harzic. M Harzic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marque‐Juillet, Stéphanie, et al.. (2009). Faut-il rechercher une hépatite B occulte chez les patients infectés par le virus de l’immunodéficience humaine (VIH) ?. Pathologie Biologie. 58(2). e39–e42. 7 indexed citations
2.
Marque‐Juillet, Stéphanie, et al.. (2009). Évaluation de la quantification du cytomégalovirus dans le sang par le test de PCR en temps réel CMV R-gene®. Pathologie Biologie. 58(2). 162–165. 1 indexed citations
3.
Dommergues, M.-A., et al.. (2007). Épidémie estivale de méningites à entérovirus en 2005: expérience d'un service de pédiatrie générale. Archives de Pédiatrie. 14(8). 964–970. 10 indexed citations
4.
Ghosn, Jade, Isabelle Pellegrin, Cécile Goujard, et al.. (2006). HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time. AIDS. 20(2). 159–170. 85 indexed citations
5.
Moreau, Alain, S. Brunet, Syria Laperche, et al.. (2006). Group O Human Immunodeficiency Virus Type 1 Infection That Escaped Detection in Two Immmunoassays. Journal of Clinical Microbiology. 44(2). 662–665. 24 indexed citations
6.
Heilbronner, Claire, et al.. (2004). Infection à cowpox virus chez l’enfant. Archives de Pédiatrie. 11(4). 335–339. 8 indexed citations
7.
Chaix, Marie‐Laure, Diane Descamps, M Harzic, et al.. (2003). Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS. 17(18). 2635–2643. 89 indexed citations
8.
Descamps, Diane, Vincent Cálvez, Jacques Izopet, et al.. (2001). Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study. AIDS. 15(14). 1777–1782. 30 indexed citations
9.
Ngo‐Giang‐Huong, Nicole, Christiane Deveau, Isabelle Pellegrin, et al.. (2001). Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy. AIDS. 15(6). 665–673. 98 indexed citations
10.
Garrigue, Isabelle, Isabelle Pellegrin, Bruno Hoën, et al.. (2000). Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA. AIDS. 14(18). 2851–2855. 40 indexed citations
11.
Bécheur, Hakim, et al.. (2000). [Hepatitis C virus contamination of endoscopes and biopsy forceps].. PubMed. 24(10). 906–10. 20 indexed citations
12.
Hoen, Bruno, M Harzic, Alain Venet, et al.. (1999). Highly Active Antiretroviral Treatment Initiated Early in the Course of Symptomatic Primary HIV‐1 Infection: Results of the ANRS 053 Trial. The Journal of Infectious Diseases. 180(4). 1342–1346. 57 indexed citations
13.
Dalod, Marc, M Harzic, Isabelle Pellegrin, et al.. (1998). Evolution of Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus Type 1 in Patients with Symptomatic Primary Infection Receiving Antiretroviral Triple Therapy. The Journal of Infectious Diseases. 178(1). 61–69. 72 indexed citations
14.
Zucman, David, et al.. (1997). Correlation between body composition, caloric intake and plasma viral load in HIV infected patients. Nutrition. 13(3). 292–292. 7 indexed citations
15.
Peynet, J, et al.. (1996). Infection sévère à parvovirus B19 chez un enfant hémophile A immunocompétent. Archives de Pédiatrie. 3(1). 35–39. 6 indexed citations
16.
Mentec, Hervé, Catherine Leport, J Leport, et al.. (1994). Cytomegalovirus colitis in HIV-1-infected patients. AIDS. 8(4). 461–468. 38 indexed citations
17.
Salmon, Dominique, F. Lacassin, M Harzic, et al.. (1990). Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. Journal of Medical Virology. 32(3). 160–163. 54 indexed citations
18.
Harzic, M, et al.. (1987). [Value of the detection of serum anti-cytomegalovirus antibodies applied to the diagnosis of recent infection].. PubMed. 138(5). 331–3. 2 indexed citations
19.
Brun‐Vézinet, Françoise, Christine Katlama, Dominique Roulot, et al.. (1987). LYMPHADENOPATHY-ASSOCIATED VIRUS TYPE 2 IN AIDS AND AIDS-RELATED COMPLEX. The Lancet. 329(8525). 128–132. 97 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Phillips Breakdown of academic impact, for papers by M. Dia Breakdown of academic impact, for papers by Stefan Lindbäck Breakdown of academic impact, for papers by Perpétua Gómes Breakdown of academic impact, for papers by N. Hallam Breakdown of academic impact, for papers by P Pehrson Breakdown of academic impact, for papers by Lars Moberg Breakdown of academic impact, for papers by F de Wolf Breakdown of academic impact, for papers by Milenka V. Vargas Breakdown of academic impact, for papers by H. Farzadegan
Rankless by CCL
2026